Physician profile
John Di Preta
NPI 1477563187
$2,449.31
in general payments reported to CMS, 2019-2025
10 companies · $631 in 2025
The $631 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $611 · 2020: $191 · 2021: $73.62 · 2022: $406 · 2023: $237 · 2024: $299 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,167.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $769.03 | 2019-2025 | Incompass Total Ankle System, T2 Alpha, Adapt |
| Zimmer Biomet Holdings, INC. | $334.59 | 2019-2023 | Trabecular Metal |
| Prodigy Surgical Distribution, INC. | $320.11 | 2022-2024 | |
| Arthrex, INC. | $292.00 | 2025 | Arthrex |
| Depuy Synthes Sales INC. | $268.13 | 2019-2024 | Minibunion, Lcp, Fibergraft Aeridyan Matrix |
| Treace Medical Concepts, INC. | $145.68 | 2023-2025 | |
| Si-Bone, INC. | $113.70 | 2022 | |
| Ethicon US, LLC | $87.04 | 2025 | Ethicon, Dermabond, Stratafix |
| Axogen | $85.74 | 2023 | Avance Nerve Graft |
| Exactech, INC. | $33.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Di Preta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.